| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ALLERGAN PLC | 45,000 | 13,656,000 | 4.43% | ||
| 2 | FLAMEL TECHNOLOGIES SA SPONSORED ADR | 575,000 | 12,184,000 | 3.95% | ||
| 3 | BIOGEN INC | 30,000 | 12,118,000 | 3.93% | ||
| 4 | NUVASIVE INC COM | 235,000 | 11,134,000 | 3.61% | ||
| 5 | ALNYLAM PHARMACEUTICALS INC | 90,000 | 10,788,000 | 3.50% | ||
| 6 | FIVE PRIME THERAPEUTICS INC | 425,000 | 10,557,000 | 3.42% | ||
| 7 | INTUITIVE SURGICAL INC | 20,000 | 9,690,000 | 3.14% | ||
| 8 | ENDO INTL | 120,000 | 9,558,000 | 3.10% | ||
| 9 | GW PHARMACEUTICALS PLC | 75,000 | 9,213,000 | 2.99% | ||
| 10 | ALEXION PHARMACEUTIC | 50,000 | 9,039,000 | 2.93% | ||
| 11 | PORTOLA PHARMACEUTICALS INC | 170,000 | 7,744,000 | 2.51% | ||
| 12 | VERTEX PHARMACEUT | 60,000 | 7,409,000 | 2.40% | ||
| 13 | HORIZON PHARMA PLC | 200,000 | 6,948,000 | 2.25% | ||
| 14 | GENMARK DIAGNOSTICS INC COM | 750,000 | 6,795,000 | 2.20% | ||
| 15 | NANOSTRING TECHNOLOGIES INC | 400,000 | 6,168,000 | 2.00% | ||
| 16 | Esperion Therapeutics Inc | 75,000 | 6,132,000 | 1.99% | ||
| 17 | CEPHEID | 100,000 | 6,115,000 | 1.98% | ||
| 18 | CIGNA CORPORATION | 37,500 | 6,075,000 | 1.97% | ||
| 19 | EPIZYME INC COM | 250,000 | 6,000,000 | 1.94% | ||
| 20 | NEUROCRINE BIOSCIE COM USD0.001 | 122,500 | 5,851,000 | 1.90% | ||
| 21 | AMICUS THERAPEUTICS INC | 375,000 | 5,306,000 | 1.72% | ||
| 22 | Atara Biotherapeutics Inc | 100,000 | 5,276,000 | 1.71% | ||
| 23 | DEXCOM | 65,000 | 5,199,000 | 1.68% | ||
| 24 | AETNA INC NEW | 40,000 | 5,098,000 | 1.65% | ||
| 25 | Anacor Pharmaceuticals Inc | 65,000 | 5,033,000 | 1.63% | ||
| 26 | UNIQURE NV | 185,000 | 4,995,000 | 1.62% | ||
| 27 | ENDOCHOICE HLDGS INC | 300,000 | 4,905,000 | 1.59% | ||
| 28 | PTC THERAPEUTICS INC | 100,000 | 4,813,000 | 1.56% | ||
| 29 | CELLECTIS S A | 125,000 | 4,510,000 | 1.46% | ||
| 30 | VANDA PHARMACEUTICALS INC COM | 350,000 | 4,442,000 | 1.44% | ||
| 31 | ZELTIQ AESTHETICS INCORPORATED | 150,000 | 4,421,000 | 1.43% | ||
| 32 | CYNAPSUS THERAPEUTICS INC | 262,696 | 4,279,000 | 1.39% | ||
| 33 | IRONWOOD PHARMACEUTICALS INC COM CL A | 350,000 | 4,221,000 | 1.37% | ||
| 34 | SAGE THERAPEUTICS | 57,500 | 4,198,000 | 1.36% | ||
| 35 | VITAE PHARMACEUTICALS INC | 289,200 | 4,164,000 | 1.35% | ||
| 36 | WRIGHT MEDICAL GROUP NV | 150,000 | 3,939,000 | 1.28% | ||
| 37 | ALCOBRA LTD | 600,000 | 3,924,000 | 1.27% | ||
| 38 | Sunesis Pharmaceuticals I | 1,250,000 | 3,763,000 | 1.22% | ||
| 39 | GENOCEA BIOSCIENCES INC | 270,000 | 3,707,000 | 1.20% | ||
| 40 | ASSEMBLY BIOSCIENCES INC | 175,000 | 3,371,000 | 1.09% | ||
| 41 | ANTHEM INC | 20,000 | 3,283,000 | 1.06% | ||
| 42 | ROCKWELL MED INC COM | 200,000 | 3,224,000 | 1.04% | Call | |
| 43 | KEMPHARM INC | 175,000 | 3,215,000 | 1.04% | ||
| 44 | Lion Biotechnologies | 350,000 | 3,210,000 | 1.04% | ||
| 45 | THERAPEUTICSMD INC | 400,000 | 3,144,000 | 1.02% | ||
| 46 | AXOVANT SCIENCES LTD | 135,000 | 2,751,000 | 0.89% | ||
| 47 | Foamix Pharmaceuticals Ltd. | 250,000 | 2,563,000 | 0.83% | ||
| 48 | AVALANCHE BIOTECHNOLOGIES IN | 150,000 | 2,436,000 | 0.79% | Call | |
| 49 | BioDelivery Sciences International Inc | 300,000 | 2,388,000 | 0.77% | ||
| 50 | SAGE THERAPEUTICS | 31,700 | 2,314,000 | 0.75% | Call |
Portfolio data is normalized using SEC Form 13F filings, including the Restatement filing (0001140361-15-034669, filed 2015.09.09).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
